Monogram Technologies Inc.

DB:J7J Stock Report

Market Cap: €87.5m

Monogram Technologies (J7J) Stock Overview

Engages in developing surgical robot to enable placement of patient optimized orthopedic implants in the United States. More details

J7J fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Rewards

Revenue is forecast to grow 58.28% per year

Risk Analysis

Makes less than USD$1m in revenue ($0)

Has less than 1 year of cash runway

Currently unprofitable and not forecast to become profitable over the next 3 years

Volatile share price over the past 3 months compared to the German market


J7J Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

INBS logo
Intelligent Bio Solutions
JO
Jolt_Communications
Community Contributor

The Future of Drug Testing? Fingerprint Tech Shows Serious Promise

Key Takeaways Intelligent Bio Solutions has a new way to test for drugs using fingerprints: it’s quick, portable, and doesn’t require pee cups or saliva swabs. With commercial traction in 24 countries and over 450 active accounts, INBS is now targeting the U.S. market, where over 55 million drug tests are performed annually.
View narrative
US$2.98
FV
43.6% undervalued intrinsic discount
59.20%
Revenue growth p.a.
8users have liked this narrative
0users have commented on this narrative
42users have followed this narrative
26 days ago author updated this narrative

Monogram Technologies Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Monogram Technologies
Historical stock prices
Current Share PriceUS$2.42
52 Week HighUS$3.76
52 Week LowUS$1.69
Beta0.41
1 Month Change11.01%
3 Month Change-9.70%
1 Year Change43.20%
3 Year Changen/a
5 Year Changen/a
Change since IPO-21.91%

Recent News & Updates

Recent updates

Shareholder Returns

J7JDE Medical EquipmentDE Market
7D0.8%1.4%2.5%
1Y43.2%-11.1%17.1%

Return vs Industry: J7J exceeded the German Medical Equipment industry which returned -11.1% over the past year.

Return vs Market: J7J exceeded the German Market which returned 17.1% over the past year.

Price Volatility

Is J7J's price volatile compared to industry and market?
J7J volatility
J7J Average Weekly Movement8.2%
Medical Equipment Industry Average Movement7.1%
Market Average Movement5.8%
10% most volatile stocks in DE Market12.2%
10% least volatile stocks in DE Market3.1%

Stable Share Price: J7J's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: J7J's weekly volatility has decreased from 16% to 8% over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
201527Ben Sexsonwww.monogramtechnologies.com

Monogram Technologies Inc. engages in developing surgical robot to enable placement of patient optimized orthopedic implants in the United States. It intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. The company was formerly known as Monogram Orthopaedics, Inc. and changed its name to Monogram Technologies Inc. in May 2024.

Monogram Technologies Inc. Fundamentals Summary

How do Monogram Technologies's earnings and revenue compare to its market cap?
J7J fundamental statistics
Market cap€87.48m
Earnings (TTM)-€13.58m
Revenue (TTM)n/a
0.0x
P/S Ratio
-6.4x
P/E Ratio

Is J7J overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
J7J income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other ExpensesUS$16.01m
Earnings-US$16.01m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-0.45
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0%

How did J7J perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/01 14:42
End of Day Share Price 2025/07/01 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Monogram Technologies Inc. is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jason WittesRoth Capital Partners
Thomas KerrZacks Small-Cap Research